Follow
Yin Liu
Yin Liu
Verified email at tongji.edu.cn
Title
Cited by
Cited by
Year
Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification
HH He, CA Meyer, SS Hu, MW Chen, C Zang, Y Liu, PK Rao, T Fei, H Xu, ...
Nature methods 11 (1), 73-78, 2014
2592014
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
S Chen, G Zhu, Y Yang, F Wang, YT Xiao, N Zhang, X Bian, Y Zhu, Y Yu, ...
Nature cell biology 23 (1), 87-98, 2021
2362021
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
KL Morel, AV Sheahan, DL Burkhart, SC Baca, N Boufaied, Y Liu, X Qiu, ...
Nature cancer 2 (4), 444-456, 2021
1382021
Transcriptional landscape of the human cell cycle
Y Liu, S Chen, S Wang, F Soares, M Fischer, F Meng, Z Du, C Lin, ...
Proceedings of the National Academy of Sciences 114 (13), 3473-3478, 2017
1362017
Genome-wide association study identifies two risk loci for tuberculosis in Han Chinese
R Zheng, Z Li, F He, H Liu, J Chen, J Chen, X Xie, J Zhou, H Chen, X Wu, ...
Nature Communications 9 (1), 4072, 2018
502018
Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
X Wu, J Yang, G Tan, H Liu, Y Liu, Y Guo, R Gao, B Wan, F Yu
Frontiers in cellular and infection microbiology 9, 345, 2019
342019
Antimicrobial Susceptibility of Mycobacterium abscessus Complex Clinical Isolates from a Chinese Tertiary Hospital
Y Guo, X Cao, J Yu, Q Zhan, J Yang, X Wu, B Wan, Y Liu, F Yu
Infection and Drug Resistance, 2001-2010, 2020
182020
CRISPR screens identify essential cell growth mediators in BRAF inhibitor-resistant melanoma
Z Li, B Wang, S Gu, P Jiang, A Sahu, CH Chen, T Han, S Shi, X Wang, ...
Genomics, Proteomics and Bioinformatics 18 (1), 26-40, 2020
162020
An integrative pharmacogenomic approach identifies two-drug combination therapies for personalized cancer medicine
Y Liu, T Fei, X Zheng, M Brown, P Zhang, XS Liu, H Wang
Scientific Reports 6 (1), 22120, 2016
142016
The clinicopathological characteristics, prognosis and immune microenvironment mapping in MSI-H/MMR-D endometrial carcinomas
Y Guo, Y Liu, W Zhang, H Luo, P Shu, G Chen, Y Li
Discover Oncology 13 (1), 12, 2022
132022
Towards pathway-centric cancer therapies via pharmacogenomic profiling analysis of ERK signalling pathway
H Wang, X Zheng, T Fei, J Wang, X Li, Y Liu, F Zhang
Clinical and Translational Medicine 4, 1-9, 2015
42015
Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the rpoB gene of Mycobacterium tuberculosis clinical isolates in …
Y Guo, X Cao, J Yang, X Wu, Y Liu, B Wan, L Hu, H Wang, F Yu
Journal of Medical Microbiology 70 (3), 001317, 2021
32021
Genotypic characterization of katG, inhA, and ahpC in isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Shanghai, China
X Cao, Q Zhan, Y Guo, J Yang, Y Liu, B Wan, X Wu, Q Zhong, Y Hang, ...
Jundishapur Journal of Microbiology 12 (11), 2019
32019
Expression profiling of MYOZ1 gene in porcine tissue and C2C12 cells.
Y Liu, K Zhou, XY Li, SH Zhao, JH Cao
Journal of animal and veterinary advances 10 (15), 1917-1921, 2011
32011
The system can't perform the operation now. Try again later.
Articles 1–14